New Anti-VEGF Drug Promising for Wet Macular Degeneration

OPT-302, a new vascular endothelial growth factor (VEGF) inhibitor, appears to be safe and shows signs it could slow the progression of neovascular age-related macular degeneration.
Medscape Medical News

Full Story →